A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type IIAdaptation of the ecarin clotting time to the Act II device
- 30 June 2000
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 119 (6), 1278-1283
- https://doi.org/10.1067/mtc.2000.106088
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A NEW ASSAY FOR POINT OF CARE MONITORING OF HEPARIN AND HEPARINOID ANTI-Xa ACTIVITYAnesthesia & Analgesia, 1999
- Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- Emergent Cardiopulmonary Bypass in Five Patients with Heparin-induced Thrombocytopenia Type II Employing Recombinant HirudinAnesthesiology, 1998
- MONITORING OF RECOMBINANT HIRUDIN: ASSESSMENT OF A PLASMA-BASED ECARIN CLOTTING TIME ASSAYThrombosis Research, 1997
- Monitoring of r-Hirudin Anticoagulation during Cardiopulmonary Bypass – Assessment of the Whole Blood Ecarin Clotting TimeThrombosis and Haemostasis, 1997